Anthony R. Chase, Director at AVI BIOPHARMA INC (AVII), bought 20,000 shares at $1.20 ($24K) on 2011-09-13, disclosed to the SEC on 2011-09-14.
Open-market purchase of $24k AVII by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| LYB | BUY | 2023-07-10 | $3K | — | Filing → |
| APC | BUY | 2017-05-18 | $200K | — | Filing → |
| APC | BUY | 2014-09-02 | $189K | — | Filing → |